IMDRF Tackles Confusion Over Clinical Evidence Expectations for Device Software
This article was originally published in SRA
Executive Summary
If all goes to plan, the International Medical Device Regulators Forum will have completed by July a draft guidance that explores when and to what level clinical evaluation and evidence is necessary or acceptable to support marketing authorizations of software as a medical device (SaMD)1.